Novaccess Global (Novaccess Global) Risk Assessment

View and export this data going back to . Start your Free Trial

What is Novaccess Global Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Novaccess Global is: No Data: Cannot be evaluated.

Competitive Comparison of Novaccess Global's Risk Assessment

For the Biotechnology subindustry, Novaccess Global's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novaccess Global's Risk Assessment Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novaccess Global's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Novaccess Global's Risk Assessment falls into.

Novaccess Global (OTCPK:XSNX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Novaccess Global Risk Assessment Related Terms

Thank you for viewing the detailed overview of Novaccess Global's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Novaccess Global (Novaccess Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novaccess Global Inc (OTCPK:XSNX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

8485 E,Washington Street, No. 127, Chagrin Falls, OH, USA, 44023

Website

https://www.novaccessglobal.com

Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.

Executives

Jason Michael Anderson	director	8584 E. WASHINGTON STREET, NO. 127, CHAGRIN FALLS OH 44023
John Cassarini	director	880 WINTER STREET, BUILDING 4, WALTHAM MA 02451
Neil J Laird	officer: Chief Financial Officer
Larry Michael Yukich	officer: Chief Financial Officer	8834 MAYFIELD ROAD, SUITE C, CHESTERLAND OH 44026
Dwain Morris-irvin	officer: Chief Executive Officer	8834 MAYFIELD ROAD, SUITE C, CHESTERLAND OH 44026
Innovest Global, Inc.	10 percent owner	8834 MAYFIELD ROAD, CHESTERLAND OH 44026
Daniel G. Martin	director, 10 percent owner, officer: Chief Executive Officer	8834 MAYFIELD RD, CHESTERLAND OH 44026
Michael A Russak	director
Osmund Mark Fundingsland	director	1237 LAS PALMAS DR, SANTA BARBARA CA 93110
Thomas A Anderson	director	2116 PASEO PRIMERO, SANTA FE NM 87501
Jeff J Huitt	officer: CFO	10651 WEST 34TH PLACE, WHEAT RIDGE CO 80033
Joseph Grimes	officer: COO	6 CLEOME, LADERA RANCH CA 92694
Tom M Djokovich	director, 10 percent owner, officer: President	23332 VISTA CARILLO, LAGUNA NIGUEL CA 92677
Brian Altounian	director, officer: Secretary	626 N. DOHENY DRIVE, WEST HOLLYWOOD CA 90069
Thomas Djokovich	director, officer: President	1601 CLOVERFIELD BLVD, 2ND FL. S. TOWER, SANTA MONICA CA 90404